iShares Biotechnology ETF $IBB Position Lessened by True Vision MN LLC

True Vision MN LLC decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 67.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,511 shares of the financial services provider’s stock after selling 9,280 shares during the period. True Vision MN LLC’s holdings in iShares Biotechnology ETF were worth $762,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 2nd quarter worth about $25,000. Basepoint Wealth LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $29,000. Copia Wealth Management acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $34,000. Finally, Caitlin John LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $173.64 on Monday. The business has a 50 day simple moving average of $170.61 and a 200 day simple moving average of $170.67. iShares Biotechnology ETF has a 52 week low of $123.61 and a 52 week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.